Trial Profile
A Phase 4, Randomized, Double-blind, Placebo-controlled, Crossover Study to Investigate the Clinical Benefit of Midodrine Hydrochloride in Male and Female Subjects With Symptomatic Orthostatic Hypotension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jun 2021
Price :
$35
*
At a glance
- Drugs Midodrine (Primary)
- Indications Orthostatic hypotension
- Focus Therapeutic Use
- Sponsors Shire
- 08 Apr 2015 New trial record